Anton Gueth began his career in the pharmaceutical business over 20 years ago at Eli Lilly and Company. His global finance and operating experience spans the U.S., Europe, the Middle East, and Africa. Before joining EVOLUTION Life Science Partners, Mr. Gueth was a Managing Director of Burrill Securities. He is also the founder and Managing Partner of GUETH CONSULTING LLC, a consulting firm focusing on pharmaceutical and biotechnology clients in the areas of licensing, early stage financing, and alliance management. His clients over the years have included Amgen, Baxter, Boehringer Ingelheim, and Bayer, among many others.
While at Lilly, Mr. Gueth held multiple positions of increasing responsibility, including Area Director Africa/Middle East and concluding as Director of Alliance Management. Mr. Gueth is a member of the board of directors of Antares Pharma. He is also on the board of the California chapter of the American Liver Foundation. Mr. Gueth received his master’s degree in public affairs from Indiana University and an M.S. in agricultural economics from Justus Liebig University in Germany.